Implantable cardioverter defibrillator use
DeviceImplantation of an implantable cardioverter defibrillator (epicardial or transvenous)
NCT Number: NCT05349162
This observational study included all patients <18-year-old implanted with an Implantable cardioverter defibrillator (ICD) at Necker Hospital, Paris, France, from January 2003 to January 2021. Outcomes (ICD-related complications and reinterventions) were compared between epicardial and transvenous ICDs using Cox proportional hazard models.
Looking for future studies?
Notify Me0 year–18 year
All sexes
Observational
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Implantation of an implantable cardioverter defibrillator (epicardial or transvenous)
Time frame: up to 15 years
Number of patients in each group (epicardial and transvenous implantable cardioverter defibrillator) with an implantable cardioverter defibrillator dysfunction (dysfunction of at least one lead requiring reintervention) at the end of the follow-up
Paris Cardiovascular Research Center (Inserm U970)
Other Gov
Epicardial Versus Transvenous Implantable Cardioverter Defibrillators in Children
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05938283
Aortic Stenosis, Subvalvular, Aortic Valve Disease
London, United Kingdom
View Trial DetailsNCT04141891
Acute Coronary Syndrome, Aortic Stenosis, Subvalvular
La Jolla, California, United States
View Trial DetailsNCT02976961
Behavior, Distress
Gentofte Municipality, Hellerup, Denmark
View Trial DetailsNCT03884608
Behavior, Cardiomyopathies
Birmingham, Alabama, United States
View Trial Details